• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT NAVION; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT NAVION; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR Back to Search Results
Model Number VNMC4034C200TJ
Device Problems Leak/Splash (1354); Material Deformation (2976)
Patient Problem Hemoptysis (1887)
Event Date 11/09/2021
Event Type  Injury  
Event Description
Valiant navion stent grafts were implanted during an endovascular procedure for the treatment of a 57mm thoracic aortic aneurysm.It was reported approximately 2 years post the index procedure the patient presented with haemoptysis.A ct identified aneurysm enlargement and evidence of stent ring enlargement.It also was observed that the junction of the stent graft come off.  as per the physician the cause of the event could not be determined.  no additional clinical sequelae was provided and the patient is fine.
 
Manufacturer Narrative
Other relevant device(s) are: product id: vnmc4646c55tj, serial/lot #: (b)(4), ubd: 01-sep-2021, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information received: it was confirmed that the original implanted device was not a navion device.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Core lab review of ct imaging from 07-nov-2021 identified an new unknown endoleak.No stent fracture was observed on vnmc4646c55tj ((b)(6)).It was noted as non evaluable for stent fracture on vnmc4034c200tj ((b)(6)) due to device overlap.No stent ring en largement or stent ring displacement was identified.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT NAVION
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
EI 
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
EI  
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key12809792
MDR Text Key280744914
Report Number9612164-2021-04405
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup,Followup
Report Date 07/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/15/2021
Device Model NumberVNMC4034C200TJ
Device Catalogue NumberVNMC4034C200TJ
Was Device Available for Evaluation? No
Date Returned to Manufacturer11/10/2021
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/10/2021
Initial Date FDA Received11/15/2021
Supplement Dates Manufacturer Received03/22/2022
06/29/2022
Supplement Dates FDA Received04/13/2022
07/04/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured09/16/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-1201-2021
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age71 YR
Patient SexMale
-
-